Corrow KA, Vizzard MA. Phosphorylation of extracellular signal-regulated kinases in urinary bladder in rats with cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol 293: R125-R134, 2007. First published April 4, 2007; doi:10.1152/ajpregu.00857.2006.-Phosphorylated ERK expression has been demonstrated in the central and peripheral nervous system after various stimuli, including visceral stimulation. Changes in the activation (i.e., phosphorylation) of extracellular signal-regulated kinases (pERK) were examined in the urinary bladder after 4 h (acute), 48 h (intermediate), or chronic (10 day) cyclophosphamide (CYP) treatment. CYP-induced cystitis significantly (P Յ 0.01) increased pERK expression in the urinary bladder with intermediate (48 h) and chronic CYP treatment. Immunohistochemistry for pERK immunoreactivity revealed little pERK-IR in control or acute (4 h) CYP-treated rat urinary bladders. However, pERK expression was significantly (P Յ 0.01) upregulated in the urothelium after 48 h or chronic CYP treatment. Whole mount preparations of urothelium/lamina propria or detrusor smooth muscle from control (noninflamed) rats showed no pERK-IR in PGP9.5-labeled nerve fibers in the suburothelial plexus. However, with CYP-treatment (48 h, chronic), a few pERK-IR nerve fibers in the suburothelial plexus of whole mount preparations of bladder and at the serosal edge of urinary bladder sections were observed. pERK-IR cells expressing the CD86 antigen were also observed in urinary bladder from CYP-treated rats (48 h, chronic). Treatment with the upstream inhibitor of ERK phosphorylation, U0126, significantly (P Յ 0.01) increased bladder capacity in CYP-treated rats (48 h). These studies suggest that therapies targeted at pERK pathways may improve urinary bladder function in CYPtreated rats.neurotrophins; mitogen-activated protein kinase; plasticity; inflammation; urothelium; U0126 THE P44 AND P42 MITOGEN-ACTIVATED protein kinases (p44/42 MAPKs)/extracellular signal-regulated kinases (ERK1 and ERK2) are members of the serine/threonine protein kinases involved in the transduction of neurotrophic and neurochemical signals (18,36,38,49). ERKs play important roles in cell proliferation, differentiation, survival, memory formation, and neuronal plasticity (36, 38). ERKs are activated (i.e., phosphorylated) in the dorsal horn of the spinal cord and in brain stem nuclei after peripheral somatic or visceral (9, 15-17, 45) stimulation or inflammation. The chemically cyclophosphamide (CYP)-induced bladder inflammation model is associated with alterations in neurochemical (50, 54), electrophysiological (57), organizational (55), and functional properties (20) of micturition pathways. These changes may be mediated by chemical mediators (e.g., neurotrophins, cytokines, neuropeptides) produced in the bladder, spinal cord, or dorsal root ganglia with cystitis (6,32,50,53,54).Nerve growth factor (NGF) interactions with the highaffinity receptor, TrkA, may contribute to phosphorylated ERK expression in the urinar...